Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection
Human papillomavirus (HPV) infection is a frequent cause of malignant and non-malignant disease, in particular among persons with HIV. HPV serotype-specific anti L1 antibodies protect against HPV infection but little is known about prophylactic HPV vaccine-induced cell-mediated immunity against HPV...
Saved in:
Main Authors: | Maria Zurek Munk-Madsen (Author), Lars Toft (Author), Tina Kube (Author), Rolf Richter (Author), Lars Ostergaard (Author), Ole S. Søgaard (Author), Martin Tolstrup (Author), Andreas M. Kaufmann (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reactogenicity of Cervarix and Gardasil human papillomavirus (HPV) vaccines in a randomized single blind trial in healthy UK adolescent females
by: Tao Haskins-Coulter, et al.
Published: (2017) -
TLR9-adjuvanted pneumococcal conjugate vaccine induces antibody-independent memory responses in HIV-infected adults
by: Rasmus Offersen, et al.
Published: (2012) -
Immune checkpoints and the HIV-1 reservoir: proceed with caution
by: Rikke Olesen, et al.
Published: (2016) -
A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil®)
by: Vandana A Govan
Published: (2008) -
Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9
by: Nitesh K. Kunda, et al.
Published: (2019)